| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.02B | +31.1% | +61.2% |
| Cost of Revenue | $1.48B | -8.5% | +16.9% |
| Gross Profit | $1.54B | +124.3% | +154.3% |
| R&D Expense | $327.0M | +3.5% | +17.2% |
| SG&A Expense | $139.0M | -22.3% | -2.1% |
| Operating Income | $1.06B | +505.1% | +446.2% |
| Pre-tax Income | $937.0M | +655.6% | +441.6% |
| Income Tax | $134.0M | +1016.7% | +94.2% |
| Net Income | $803.0M | +617.0% | +672.1% |
| EPS (Basic) | $5.46 | +609.1% | +658.3% |
| EPS (Diluted) | $5.15 | +586.7% | +615.3% |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.54B | +6.7% | +91.4% |
| Accounts Receivable | $1.24B | +3.9% | +37.1% |
| Inventory | $1.97B | +3.3% | -9.3% |
| Current Assets | $5.15B | +3.3% | +15.6% |
| Total Assets | $13.00B | +2.0% | -8.7% |
| Current Liabilities | $1.65B | +9.1% |
| Line Item | 2026-01-02 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.51B | +208.8% | — |
| Capital Expenditures | $89.0M | +78.0% | — |
| Investing Cash Flow | -$180.0M | -1100.0% | — |
| Financing Cash Flow | -$1.27B | -147.2% | — |
| Free Cash Flow | $1.42B | +223.7% | — |
| -11.7% |
| Long-term Debt | $603.0M | -55.4% | — |
| Total Liabilities | $2.79B | -17.3% | +24.7% |
| Stockholders' Equity | $10.21B | +8.9% | -14.9% |